Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Trinkmann (Heidelberg, Germany), J. Schäfer (Mannheim, Germany), F. Trudzinski (Heidelberg, Germany), J. Gawlitza (Mannheim, Germany), J. Saur (Mannheim, Germany), I. Akin (Mannheim, Germany), M. Borggrefe (Mannheim, Germany), T. Ganslandt (Mannheim, Germany), F. Herth (Heidelberg, Germany), R. Buhl (Mainz, Germany). Small airway disease (SAD) is associated with respiratory symptoms and relevant for therapy in early COPD. 5234

Member's Comments

No comment yet.

Related content which might interest you: The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Interpreting thresholds for a clinically significant change in health status in asthma and COPD Source: Eur Respir J 2002; 19: 398-404 Year: 2002 The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 540s Year: 2003 The influence of co-morbidity on the outcome of non-invasive ventilatory support in patients with acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 277s Year: 2002 Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Where current pharmacological therapies fall short in COPD: symptom control is not enough Source: Eur Respir Rev 2007; 16: 98-104 Year: 2007 The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008 Vocal cord dysfunction (VCD) in hospitalised exacerbations of asthma and chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Person-centred approaches to COPD and asthma care Year: 2019 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy? Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes Source: Eur Respir J 2003; 21: 30S-35S Year: 2003 Bronchodilator-induced changes in dynamic hyperinflation but not in airway obstruction are associated with improvement in dyspnoea in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 174s Year: 2001 Socioeconomic risk factors for COPD and respiratory symptoms in a general population Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Why is it important to consider (sub)phenotypes of asthma and COPD? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013